Prograf ( DrugBank: - )

3 diseases

60. 再生不良性貧血

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-006577-25-SE (EUCTR)	25/07/2007	11/06/2007	A prospective randomized study comparing rapamune and tacrolimus vs. cyclosporine and methotrexate a ...	A prospective randomized study comparing rapamune and tacrolimus vs. cyclosporine and methotrexate a ...	Graft versus host disease prophylaxis in patients receiving stem cell transplantation due to: chroni ...	Trade Name: Rapamune Product Name: Rapamune INN or Proposed INN: SIROLIMUS Other descriptive name: Rapa ...	Karolinska Institutet	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200		Finland;Sweden

臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003233-38-IT (EUCTR)	06/04/2021	04/06/2021	A Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropa ...	A PHASE III, RANDOMIZED, OPEN-LABEL ACTIVE COMPARATOR-CONTROLLED MULTICENTER STUDY TO EVALUATE EFFIC ...	Primary Membranous Nephropathy (pMN) MedDRA version: 21.1;Level: LLT;Classification code 10027170;Te ...	Trade Name: Gazyvaro Product Name: Obinutuzumab Product Code: [RO5072759] INN or Proposed INN: OBINUTUZ ...	F. HOFFMANN - LA ROCHE LTD.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	140	Phase 3	United States;Spain;Ukraine;Turkey;Israel;Russian Federation;Italy;France;Canada;Argentina;Brazil;Po ...
2	EUCTR2015-001039-18-Outside-EU/EEA (EUCTR)		03/07/2015	Trial on the therapeutic effect of Tacrolimus in combination with low dosage corticosteroids compare ...	Open-Label, Randomized, Comparative, Multi-Center Clinical Trial on the Therapeutic Effect of Tacrol ...	Minimal change nephrotic syndrome;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Prograf INN or Proposed INN: TACROLIMUS Trade Name: Prograf INN or Proposed INN: TACROLIMUS ...	Astellas Pharma Korea, Inc.	NULL	NA			Female: yes Male: yes	152		Korea, Republic of

臨床試験数 : 145 / 薬物数 : 156 - (DrugBank : 51) / 標的遺伝子数 : 64 - 標的パスウェイ数 : 146

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-001501-42-FI (EUCTR)	15/05/2008	18/03/2008	Tacrolimus in the treatment of Painful Bladder Syndrome / Interstitial Cystitis	Tacrolimus in the treatment of Painful Bladder Syndrome / Interstitial Cystitis	Painful bladder syndrome / interstitial cystitis (PBS/IC) MedDRA version: 1;Level: LLT;Classificatio ...	Trade Name: Prograf INN or Proposed INN: TACROLIMUS	Jukka Sairanen	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Finland